Evidence map›Paper›PMID 28765711›Full record

ArticleNeuropsychiatric disease and treatment2017

Characteristics and predictors of progression in an Egyptian multiple sclerosis cohort: a multicenter registry study.

Sherif M Hamdy, Maged Abdel-Naseer, Nevin M Shalaby, Alaa N Elmazny, Ahmed A Nemr, Amr Hassan, Mohamed I Hegazy, Husam S Mourad, Nirmeen A Kishk, Mona A Nada and 3 more

Abstract read
In one paragraph

Article in Neuropsychiatric disease and treatment, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Sherif M HamdyNeurology Department, Cairo University.
Maged Abdel-NaseerNeurology Department, Cairo University.
Nevin M ShalabyNeurology Department, Cairo University.
Alaa N ElmaznyNeurology Department, Cairo University.
Ahmed A NemrNeurology Department, Maadi Military Hospital, Cairo, Egypt.
Amr HassanNeurology Department, Cairo University.
Mohamed I HegazyNeurology Department, Cairo University.
Husam S MouradNeurology Department, Cairo University.
Nirmeen A KishkNeurology Department, Cairo University.
Mona A NadaNeurology Department, Cairo University.
Ahmed AbdelalimNeurology Department, Cairo University.
Amr M FouadNeurology Department, Cairo University.
Hatem S ShehataNeurology Department, Cairo University.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMultiple sclerosis (MS) is a complex autoimmune disease with a heterogeneous presentation and diverse disease course. Recent studies indicate a rising prevalence of MS in the Middle East.

objectiveTo characterize the demographics and disease features of Egyptian patients attending four tertiary referral MS centers in Cairo. MATERIALS AND

methodsThis was a retrospective, observational study on 1,581 patients between 2001 and 2015. Medical records were reviewed and data were identified and extracted in a standardized electronic registry.

resultsThe mean age of disease onset was 26.6±7.8 years, with the majority being female (2.11:1). Relapsing-remitting MS was the most common type (75.1%). The main presenting symptom was motor weakness (43.9%), which was also the most frequent symptom during the disease course. Family history of MS was found in 2.28%. Higher initial Expanded Disability Status Scale score, black holes, and infratentorial lesions on initial magnetic resonance imaging were independent factors for disease progression by univariate analysis (OR 3.87 [95% CI 1.84-6.51], 4.14 [95% CI 3.08-5.58], 4.07 [95% CI 3.21-4.99], respectively); however, in multivariate analysis, only infratentorial lesions were an independent risk for disease progression (OR 6, 95% CI 2.99-12.02;

conclusionThe results from this registry - the largest for MS in the Arab region to date - are comparable to other registries with slight differences.

Indexed as

EgyptepidemiologyMiddle EastMS registrymultiple sclerosisNorth Africa

Identifiers

PMID28765711
PMCPMC5525902

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.